Cargando…
HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Federation of Immunological Societies. Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065245/ https://www.ncbi.nlm.nih.gov/pubmed/33905752 http://dx.doi.org/10.1016/j.imlet.2021.04.007 |
| _version_ | 1783682299031715840 |
|---|---|
| author | Bonaccorsi, Irene Carrega, Paolo Venanzi Rullo, Emmanuele Ducatelli, Rosaria Falco, Michela Freni, Josè Miceli, Massimiliano Cavaliere, Riccardo Fontana, Vincenzo Versace, Antonio Caramori, Gaetano David, Antonio Nunnari, Giuseppe Ferlazzo, Guido |
| author_facet | Bonaccorsi, Irene Carrega, Paolo Venanzi Rullo, Emmanuele Ducatelli, Rosaria Falco, Michela Freni, Josè Miceli, Massimiliano Cavaliere, Riccardo Fontana, Vincenzo Versace, Antonio Caramori, Gaetano David, Antonio Nunnari, Giuseppe Ferlazzo, Guido |
| author_sort | Bonaccorsi, Irene |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8065245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Federation of Immunological Societies. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80652452021-04-26 HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk Bonaccorsi, Irene Carrega, Paolo Venanzi Rullo, Emmanuele Ducatelli, Rosaria Falco, Michela Freni, Josè Miceli, Massimiliano Cavaliere, Riccardo Fontana, Vincenzo Versace, Antonio Caramori, Gaetano David, Antonio Nunnari, Giuseppe Ferlazzo, Guido Immunol Lett Correspondence European Federation of Immunological Societies. Published by Elsevier B.V. 2021-06 2021-04-24 /pmc/articles/PMC8065245/ /pubmed/33905752 http://dx.doi.org/10.1016/j.imlet.2021.04.007 Text en © 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Bonaccorsi, Irene Carrega, Paolo Venanzi Rullo, Emmanuele Ducatelli, Rosaria Falco, Michela Freni, Josè Miceli, Massimiliano Cavaliere, Riccardo Fontana, Vincenzo Versace, Antonio Caramori, Gaetano David, Antonio Nunnari, Giuseppe Ferlazzo, Guido HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title | HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title_full | HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title_fullStr | HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title_full_unstemmed | HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title_short | HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk |
| title_sort | hla-c*17 in covid-19 patients: hints for associations with severe clinical outcome and cardiovascular risk |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065245/ https://www.ncbi.nlm.nih.gov/pubmed/33905752 http://dx.doi.org/10.1016/j.imlet.2021.04.007 |
| work_keys_str_mv | AT bonaccorsiirene hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT carregapaolo hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT venanzirulloemmanuele hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT ducatellirosaria hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT falcomichela hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT frenijose hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT micelimassimiliano hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT cavalierericcardo hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT fontanavincenzo hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT versaceantonio hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT caramorigaetano hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT davidantonio hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT nunnarigiuseppe hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk AT ferlazzoguido hlac17incovid19patientshintsforassociationswithsevereclinicaloutcomeandcardiovascularrisk |